Aortic propagation velocity is a novel and simple echocardiographic parameter of aortic stiffness which is feasible for non invasive cardiovascular risk stratification and selection of high risk individuals for CAD.
Between January 2006 and December 2009, 37 radioisotope synovectomy (RS) in 18 severe haemophilic patients (factor 8<1%) have been performed at our centre. The distribution of joint injected was as follows: rhenium-186 [Re186], 19 joints (ankles, 8 and elbows, 11) and yttrium-90 [Y90] 18 joints (knees, 18). Their mean age was 12 years (range: 8-20 years). Mean follow-up period after procedure was 22.6 months. We preferred to use Y90 for all large joints and Re186 for small joints. Haemophilic patients with grade-II or III synovitis were selected for RS in our study. Radioisotope synovectomy was performed in eight ankles for seven patients, 11 elbows for seven patients and 18 knees for 13 patients. Mean bleeding counts before the procedure and after the procedure were as follows: Ankles, 3.43 vs. 0.62 (P=0.002); elbows, 3.12 vs. 0.55 (P=0.000); and 3.83 vs. 0.62 (P=0.011). No major complications requiring secondary treatments were observed. In summary, an early RS is the best way to halt the evolution of chronic haemophilia synovitis to devastating haemophilic arthropathy. Radioisotope synovectomy is very effective and safe in the treatment of chronic synovitis of children with haemophilia. Our data confirm the efficacy of RS for the treatment of chronic haemophilic synovitis, which has been previously published by many authors around the world. We highly recommend this procedure for developing countries to prevent joint disabilities. For a better and a healthier generation, RS has to be introduced in all the developing countries.
There is no need to administer extra volume of fluid to obese patients undergoing laparoscopic bariatric surgery. Use of dynamic indicators like PVI helps to decrease intraoperative volume of infused fluids with no effects on either intraoperative or postoperative lactate levels in laparoscopic bariatric interventions.
In this study, graphene nanoplatelets (GNPs) added to epoxy matrix composite reinforced by aeronautical grade carbon fibers (CFs) were fabricated by the vacuum infusion method, and the effect of different GNPs contents (0.05, 0.25, and 1.25 wt%) on electrical conductivity, flexural properties, and dynamic mechanical properties were investigated. The results revealed an 8-and 73-times improvement in conductivity values across the thickness with the addition of 0.05 and 0.25 wt% GNPs, respectively, compared to the neat composite. Flexural test results showed that with the addition of 0.05 GNP, only 6% increase in flexural strength was obtained, while with the addition of 0.25 wt% GNP flexural strength remained almost the same as for the neat composite. On the contrary, the addition of GNPs (1.25% by weight) causes a reduction in the flexural strength with respect to the neat composite. This was confirmed by the fractured surfaces examined by scanning electron microscope which reveals that considerable amount of fiber-matrix debonding was observed with 1.25 GNPs loading. Dynamic mechanical analysis (DMA) revealed that the storage modulus of the neat composite increased by 12.6% with the addition of only a small amount of GNP (0.05% wt) compared to the neat composite. Composite with 1.25 GNP shows upward bending, affecting the shape of the cole-cole plot obtained from DMA results, indicating inappropriate interactions of GNPs in both the matrix and CF in the composite.
Adjuvant yttrium-90 radiosynovectomy after surgical excision in the treatment of DPVNS is a reliable and efficient treatment method with successful clinical results. RS treatment can be considered for cases with DPVNS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.